The genetic type of the Bayanerhet Formation oil shale in the Bayanjargalan mine area is an inland lacustrine oil shale deposit. Inorganic element analysis and organic geochemical testing of oil shale samples collected in three boreholes show that the Bayanerhet Formation oil shale has relatively high organic contents, e.g., average TOC values of 6.53, 7.32 and 8.84 (corresponding to oil contents of 5.49%, 6.07% and 7.50%) in boreholes BJ3807, BJ3405 and BJ3005, respectively. Analysis of organic matter sources with biomarkers indicates that lower aquatic organisms such as algae contribute more to the organic matter than higher plants do. According to research on the values of Fe2O3/FeO, Rb/Sr and w (La) n/w (Yb)n in cores from the three boreholes, the Bayanjargalan oil shale is inferred to have formed in a humid paleoclimate with a relatively high sedimentation rate. In research on the evolution of the paleoaquifer in which the oil shale formed, the values of Fe3+/Fe2+, V/V + Ni, Ni/V, Ceanom and δCe are applas deposited under such conditions. The abundant terrigenous supply under warm and humid conditions significantly promoted the primitive biological productivity, and the weak redox saltwater environment had relatively high productivity. All the favorable conditions promoted the formation of high-quality oil shale.This current research is based on a bio-inspired procedure for the synthesis of biomolecule functionalized hybrid magnetic nanocomposite with the Fe3O4 NPs at core and Pd NPs at outer shell. The central idea was the initial modification of magnetic NP by the phytochemicals from Fritillaria imperialis flower extract, which was further exploited in the green reduction of Pd2+ ions into Pd NPs, in situ. The flower extract also acted as a capping agent for the obtained Pd/Fe3O4 composite without the need of additional toxic reagents. The as-synthesized Fe3O4@Fritillaria/Pd nanocomposite was methodically characterized over different physicochemical measures like FT-IR, ICP-AES, FESEM, EDX, TEM, XPS and VSM analysis. Thereafter, its catalytic potential was evaluated in the reduction of various nitrobenzenes to arylamines applying hydrazine hydrate as reductant in ethanol/water (12) medium under mild conditions. Furthermore, the nanocatalyst was retrieved using a bar magnet and recycled several times without considerable leaching or loss of activity. This green, bio-inspired ligand-free protocol has remarkable advantages like environmental friendliness, high yields, easy workup and reusability of the catalyst.Articular cartilage is built by chondrocytes which become less active with age. This declining function of the chondrocytes, together with the avascular nature of the cartilage, impedes the spontaneous healing of chondral injuries. These lesions can progress to more serious degenerative articular conditions as in the case of osteoarthritis. As no efficient cure for cartilage lesions exist yet, cartilage tissue engineering has emerged as a promising method aiming at repairing joint defects and restoring articular function. In the present work, we investigated if a new self-assembling peptide (referred as IEIK13), combined with articular chondrocytes treated with a chondrogenic cocktail (BMP-2, insulin and T3, designated BIT) could be efficient to restore full-thickness cartilage defects induced in the femoral condyles of a non-human primate model, the cynomolgus monkey. First, in vitro molecular studies indicated that IEIK13 was efficient to support production of cartilage by monkey articular chondrocytes treated with BIT. In vivo, cartilage implant integration was monitored non-invasively by contrast-enhanced micro-computed tomography, and then by post-mortem histological analysis and immunohistochemical staining of the condyles collected 3 months post-implantation. Our results revealed that the full-thickness cartilage injuries treated with either IEIK13 implants loaded with or devoid of chondrocytes showed similar cartilage-characteristic regeneration. This pilot study demonstrates that IEIK13 can be used as a valuable scaffold to support the in vitro activity of articular chondrocytes and the repair of articular cartilage defects, when implanted alone or with chondrocytes.Multiple studies have reported a doubling in risk of Coronavirus Disease-2019 (COVID-19) among cancer patients. Here, we examine the potential biological rationale behind this recurrent epidemiological observation. https://www.selleckchem.com/products/7acc2.html By leveraging large-scale genome-wide transcriptional data of normal and malignant tissues from adults and children, we found evidence of increased expression of SARS-CoV-2 viral entry genes in the cancer state, particularly in respiratory, gastrointestinal, and genitourinary tract tissues, with decreased expression in pediatric vs. adult samples. Additionally, by interrogating the temporal effects of radiotherapy on human peripheral blood mononuclear and mucosal cells, we observed important treatment-related alterations in host innate immunity, specifically type I interferon responses. Overall, cancers enhance expression of critical viral entry genes, and innate viral defenses can be dysregulated transiently during radiation treatments. These factors may contribute to the observed increased susceptibility to SARS-CoV-2 entry and severity of COVID-19 in cancer patients.Mobile devices, climate science, and autonomous vehicles all require advanced microwave antennas for imaging, radar, and wireless communications. We propose a waveguide-fed metasurface antenna architecture that enables electronic beamsteering from a lightweight circuit board with varactor-tuned elements. Our approach uses a unique feed structure and layout that enables spatial sampling at the Nyquist limit of half a wavelength. We detail the design of this Nyquist metasurface antenna and experimentally demonstrate electronic beamsteering in two directions. Nyquist metasurface antennas can realize high performance without costly and power hungry phase shifters, making them a compelling technology for future antenna hardware.Enzyme and chaperone therapies are used to treat Fabry disease. Such treatments are expensive and require intrusive biweekly infusions; they are also not particularly efficacious. In this pilot, single-arm study (NCT02800070), five adult males with Type 1 (classical) phenotype Fabry disease were infused with autologous lentivirus-transduced, CD34+-selected, hematopoietic stem/progenitor cells engineered to express alpha-galactosidase A (α-gal A). Safety and toxicity are the primary endpoints. The non-myeloablative preparative regimen consisted of intravenous melphalan. No serious adverse events (AEs) are attributable to the investigational product. All patients produced α-gal A to near normal levels within one week. Vector is detected in peripheral blood and bone marrow cells, plasma and leukocytes demonstrate α-gal A activity within or above the reference range, and reductions in plasma and urine globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso-Gb3) are seen. While the study and evaluations are still ongoing, the first patient is nearly three years post-infusion.